Science

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

Yüksel Ürün/X

Feb 8, 2025, 19:19

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Veronica Hernström, et al. on LinkedIn:

“Largest AI Mammography Trial: Game-Changer!

105,934 women screened.
29% more cancers detected.
44% reduction in screen-reading workload.
No rise in false positives.

AI is reshaping breast cancer screening!”

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.

Authors: Veronica Hernström, et al.

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

AI Mammography Trial Ankara University School of Medicine artificial intelligence Breast Cancer cancer fight against cancer Global fight against cancer Mammography Trial MASAI MedOnc OncoDaily Oncology Veronica Hernström Yüksel Ürün

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage